Efficacy and safety of fixed-dose combinations of aclidinium bromide/formoterol fumarate: the 24-week, randomized, placebo-controlled AUGMENT COPD study

Overview of attention for article published in Respiratory Research, October 2014

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (91st percentile)
High Attention Score compared to outputs of the same age and source (95th percentile)

Mentioned by

news: 1 news outlet
policy: 3 policy sources

f1000: 1 research highlight platform

Citations

dimensions_citation: 130 Dimensions

Readers on

mendeley: 106 Mendeley

Summary News Policy documents Research highlights Dimensions citations

So far, Altmetric has seen 1 news story.

COPD : Neue LAMA / LABA - Kombi mit zweimal täglicher Gabe

Arzte Zeitung , 28 Jan 2015

Ab 2. Februar erweitert die Fixkombi aus Aclidinium und Formoterol (Brimica® Genuair®) die Therapieoptionen bei COPD. Patienten…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity.